CHONDROPROTEC庐
Polysulfated Glycosaminoglycan
Sterile Solution
Directions for Use
1. Irrigate wound with normal saline solution.
2. Either pour contents of vial or dispense
from syringe to withdraw solution and cover
wound site.
3. Cover with a non-adherent dressing such as
PUF (polyurethane 铿乴m) or Telfa庐. Note: Subse-
quent applications of CHONDROPROTEC can
be injected through the dressing as to not
disturb the wound bed.
4. Reapply CHONDROPROTEC daily and redress
wound site every 5-7 days or as needed.
Store at controlled room temperature
(15-30掳C). Protect from freezing. Discard
unused portion.
Description Caution
CHONDROPROTEC is a sterile 10 mL solution Not for food animal use.
containing 1000 mg of Polysulfated Glycosami- No known side effects, not intended for use as
noglycan (100 mg/mL). For use on dogs, cats and a long term or permanent dressing.
horses.
Federal law restricts this device to sale by or on
the order of a licensed veterinarian.
Indications
鈥? Partial and full thickness wounds Storage
鈥? Secreting and bleeding dermal lesions Store at controlled room temperature (15-30掳C).
鈥? Trauma injuries Protect from freezing.
鈥? 1st and 2nd degree burns Discard unused portions.
鈥? Pressure ulcers (Stages I-IV)
Presentation
鈥? Surgical incisions
#08820 1000 mg/10 mL vial
鈥? Donor sites
3/box
鈥? Venous stasis ulcers
Features
鈥? 1000 mg of PSGAG in a 10 mL vial
(100 mg/mL)
鈥? Derived from bovine trachea
鈥? Preservative free
鈥? Patented technology
Neogen Corporation, 944 Nandino Blvd., Lexington, KY 40511 USA 鈥? 800/525-2022 鈥? Fax: 877/228-7229 鈥? www.neogen.com 鈥? e-mail: inform@neogen.com
漏Neogen Corporation, 2006. Neogen is a registered trademark and NeogenVet is a trademark of Neogen Corp., Lansing, MI. Chondroprotec is a registered
trademark of the Hymed Group, Bethlehem, PA. L565-0406
|